Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
TRVI | Trevi Therapeutics, Inc. | Chief Scientific Officer | $547 K | -$136 K | -19.9% | May 29, 2024 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|